Samira Kiani received her medical doctorate degree (M.D.) from Tehran University of Medical Sciences. Prior to joining ASU, she completed her postdoctoral training in the center for Synthetic Biology at Massachusetts Institute of Technology, where she worked on developing synthetic gene circuits to reprogram the function and behavior of mammalian cells based on the Clustered Regularly Interspaced short Palindromic Repeats (CRISPR)/Cas9 technology. Cas9 protein is a DNA cleaving enzyme that can be targeted to any DNA sequence by means of a small guide RNA (gRNA) and can be adapted both for gene editing and gene regulation.
University of Pittsburgh